Biogen Inc (NASDAQ:BIIB)

291.67
Delayed Data
As of Sep 24
 -1.53 / -0.52%
Today’s Change
223.25
Today|||52-Week Range
468.55
+19.12%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Biogen Inc have a median target of 427.00, with a high estimate of 647.00 and a low estimate of 296.00. The median estimate represents a +46.40% increase from the last price of 291.67.

Analyst Recommendations

The current consensus among 31 polled investment analysts is to Hold stock in Biogen Inc. This rating has held steady since September, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$4.15
Sales
$2.7B
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -26.96%
 
 
 
 
 
 
Growthannually -44.81%
 
 
 
 
 
 

Sales

Growthquarterly -3.63%
 
 
 
 
 
 
Growthannually -19.91%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.